Biosapien
Founded 2018 · 9 employees on LinkedIn · 5 known investors
Biosapien develops treatments for cancer that are delivered locally to shrink tumors, relieve symptoms, and reduce the need for surgeries.
Investors · 5
Beni Venture CapitalMiami · $100K – $250K
Globivest
Golden Gate VenturesSingapore · $473K – $60M
Global VenturesreportedDubai · $1.5M – $50M
Also in the syndicate · 1
Dara Holdings
Funding
SEC filings, press & company announcements- Undisclosed amountPre-Series AJan 2025
Global Ventures (lead), Dara Holdings, Golden Gate Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 3
by search overlapPredictive Oncology9 shared keywordsPredictive Oncology combines machine learning with data from a large privately held biobank of over 150,000 tumor samples and 3D in vitro tumor models to predict drug response for pre-clinical drug discovery. It also offers tumor drug-response testing and genomic profiling services to personalize cancer therapies, serving biopharma partners and clinical oncology.
Bioworld8 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Clementia8 shared keywordsIpsen is a biopharmaceutical group that publishes financial, legal, and non-financial reporting for shareholders, investors, and the public through documents such as its Universal Registration Document. The page is the investor reports and accounts section of the company's corporate site.
Companies competing with Biosapien for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Biosapien do?
- Biosapien develops treatments for cancer that are delivered locally to shrink tumors, relieve symptoms, and reduce the need for surgeries.
- Who are Biosapien's investors?
- Biosapien's investors include Beni Venture Capital, Globivest, Golden Gate Ventures, Global Ventures.